JP6670007B2 - パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液組成 - Google Patents
パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液組成 Download PDFInfo
- Publication number
- JP6670007B2 JP6670007B2 JP2018095202A JP2018095202A JP6670007B2 JP 6670007 B2 JP6670007 B2 JP 6670007B2 JP 2018095202 A JP2018095202 A JP 2018095202A JP 2018095202 A JP2018095202 A JP 2018095202A JP 6670007 B2 JP6670007 B2 JP 6670007B2
- Authority
- JP
- Japan
- Prior art keywords
- fermentation
- glucosidase inhibitor
- paenibacillus
- culture solution
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 title claims description 31
- 239000003888 alpha glucosidase inhibitor Substances 0.000 title claims description 31
- 241000179039 Paenibacillus Species 0.000 title claims description 19
- 230000004151 fermentation Effects 0.000 title claims description 16
- 238000000855 fermentation Methods 0.000 title claims description 16
- 239000000203 mixture Substances 0.000 title description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 229920002101 Chitin Polymers 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 102000004366 Glucosidases Human genes 0.000 claims description 2
- 108010056771 Glucosidases Proteins 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000010903 husk Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 11
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 241000592795 Paenibacillus sp. Species 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 229960002632 acarbose Drugs 0.000 description 4
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 241000700159 Rattus Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010053185 Glycogen storage disease type II Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N aldehydo-N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229940127004 drugs for type 2 diabetes Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000004502 glycogen storage disease II Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Description
本発明は、1wt%の前記無機塩抜きのカニ殻のパウダー(CSP)と、異なる比例である(0/1、0.2/1及び0.4/1)前記タンパク質(protein)とを混合させ、パエニバシラス属菌であるDSM 32521で四日間の発酵後、発酵された上澄み液であるα−グルコシダーゼ阻害剤が得られる。
本実験では、異なるパエニバシラス属菌と他の培養体を本発明の培養液に利用し、発酵して取られた上澄み液により酵母菌、細菌及び大ネズミのα−グルコシダーゼに対する活性抑制の分析をそれぞれ行う。
SSP 無機塩抜きの海老殻のパウダー
protein タンパク質
NB 市販の培養液
Claims (6)
- 0.1wt%〜2.5wt%の炭素/窒素ソースと0.01wt%〜0.2wt%の無機塩類が含まれて構成され、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産するために用いられる、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液であって、前記炭素/窒素ソースはキチンとタンパク質であり、前記キチンは、ホットアルカリプロセス法によってタンパク質を除去した無機塩抜きのカニ殻のパウダーであり、前記キチンと、前記タンパク質との最適な混合比例は、1:0.2であることを特徴とする、培養液。
- 前記タンパク質(protein)は、ペプトン(Peptone)と酵母エキス(Yeast Extract)から構成されることを特徴とする請求項1に記載の、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液。
- 前記無機塩類は、MgSO4・7H2OとK2HPO4を含むことを特徴とする請求項1に記載の、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液。
- 前記ペプトンと前記酵母エキスとの混合比例は5:3乃至7:5であり、最適比例は、6:4であることを特徴とする請求項2に記載の、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液。
- 前記キチンと、MgSO4・7H2Oとの最適な混合比例は、1:0.05であることを特徴とする請求項3に記載の、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液。
- 前記キチンと、K2HPO4との最適な混合比例は、1:0.1であることを特徴とする請求項3に記載の、パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW106121366 | 2017-06-27 | ||
TW106121366A TWI670372B (zh) | 2017-06-27 | 2017-06-27 | 一種提供類芽孢桿菌發酵生產α-葡萄糖苷酶抑制劑之培養基組成 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019004870A JP2019004870A (ja) | 2019-01-17 |
JP6670007B2 true JP6670007B2 (ja) | 2020-03-18 |
Family
ID=64692001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018095202A Active JP6670007B2 (ja) | 2017-06-27 | 2018-05-17 | パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液組成 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20180371402A1 (ja) |
JP (1) | JP6670007B2 (ja) |
CN (1) | CN109136286A (ja) |
TW (1) | TWI670372B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110699276A (zh) * | 2019-09-30 | 2020-01-17 | 广西民族大学 | 一种嗜几丁质类芽孢杆菌的菌株及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150316C (zh) * | 1999-04-06 | 2004-05-19 | 中国科学院微生物研究所 | 由烟曲霉产生的一种新的几丁质酶及其分离纯化方法 |
JP4243266B2 (ja) * | 2005-09-01 | 2009-03-25 | 国立大学法人福井大学 | パエニバチルス属細菌由来のキチナーゼ及びそれをコードする遺伝子 |
CN100999756B (zh) * | 2006-12-18 | 2010-06-02 | 浙江大学 | 用枯草芽孢杆菌和谷氨酸棒杆菌混和培养体系制备γ-聚谷氨酸的方法 |
TWI422682B (zh) * | 2012-01-17 | 2014-01-11 | Univ Tamkang | The use of Bacillus sp. For the production of surfactants and extracellular polysaccharides |
CN104946708B (zh) * | 2014-03-28 | 2018-06-12 | 上海医药工业研究院 | 一种生产非达霉素的发酵培养基以及发酵方法 |
CN103911396A (zh) * | 2014-04-25 | 2014-07-09 | 山东仙普爱瑞科技股份有限公司 | 一种枯草芽孢杆菌发酵培养基 |
KR20160041084A (ko) * | 2014-10-06 | 2016-04-18 | 재단법인 전남생물산업진흥원 | 식물병 방제 활성을 지닌 패니바실러스 엘기 bc34-6 균주 |
-
2017
- 2017-06-27 TW TW106121366A patent/TWI670372B/zh active
-
2018
- 2018-02-27 US US15/906,069 patent/US20180371402A1/en not_active Abandoned
- 2018-05-07 CN CN201810426805.0A patent/CN109136286A/zh active Pending
- 2018-05-17 JP JP2018095202A patent/JP6670007B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
TWI670372B (zh) | 2019-09-01 |
TW201905196A (zh) | 2019-02-01 |
JP2019004870A (ja) | 2019-01-17 |
US20180371402A1 (en) | 2018-12-27 |
CN109136286A (zh) | 2019-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO342031B1 (no) | Fremgangsmåte for fermentering og dyrking, fermentert planteekstrakt, fermentert planteekstraktpulver og blanding inneholdende det fermenterte planteekstraktet | |
CN101829159B (zh) | 一种富硒猴头菌菇胶囊的制备方法 | |
CN104987316B (zh) | 一种海洋真菌来源的聚酮类化合物及其治疗ii型糖尿病的应用 | |
JP6670007B2 (ja) | パエニバシラス属菌の発酵によるα−グルコシダーゼ阻害剤を生産する培養液組成 | |
CN108218587A (zh) | 一种高生物活性复合海藻肥及其制备方法 | |
CN115337331B (zh) | 一种抗糖尿病枸骨叶固态发酵物及液态发酵物的制备方法 | |
WO2022194189A1 (zh) | 一种具α-葡萄糖苷酶抑制活性的乳杆菌红毛藻发酵上清液及其用途 | |
TWI643562B (zh) | 減糖健康食品之製造方法 | |
CN111218480A (zh) | 一种高产莫纳可林k的固态发酵红曲的制备方法 | |
CN110885850A (zh) | 制备褐藻寡糖的方法及其用于改良大菱鲆品质的方法 | |
CN101724015A (zh) | 一种α-葡萄糖苷酶抑制剂及其制备方法 | |
JP7401072B2 (ja) | 微細藻類増殖促進剤及びその製造方法 | |
CN109706083B (zh) | 一种经代谢调控后抗菌活性显著增加的杜仲内生真菌 | |
KR101750288B1 (ko) | 귤응애 방제용 조성물 및 그 방제 방법 | |
CN104404103A (zh) | 一种提高马齿苋多糖的方法及该方法制备的发酵液 | |
JP6579345B2 (ja) | α−グルコシダーゼを抑制するための組成物 | |
CN112553088B (zh) | 内生真菌a871提取物及其制备方法和在制备治疗痛风药物中的应用 | |
CN116688019B (zh) | 一种改善便隐血与肠道屏障、调节肠道菌群的荔枝发酵物 | |
TWI725298B (zh) | 白茅根發酵物用於調控ldlr基因、abca1基因、ptgis基因、serpine1基因及igf2bp3基因表現量之組合物的用途 | |
CN101463331B (zh) | 一种博莱霉素的发酵培养基及发酵方法 | |
TWI557134B (zh) | 新穎之化合物與含此新穎化合物之奧特阿羅刺盤孢菌的發酵產物、含其之醫藥組成物與保健食品、其用途以及新穎之奧特阿羅刺盤孢菌 | |
TW202108157A (zh) | 蟬花子實體萃取物、其製造方法及其用於降低眼壓之用途 | |
TW200934866A (en) | A method for stimulating fruit body formation of cordyceps militaris and production of cordycepin | |
CN108208795A (zh) | 一种利用食药用菌发酵藕渣生产功能性食品的方法 | |
CN117298177A (zh) | 一种天然免疫调节剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20180517 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180725 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190104 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190522 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190604 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190821 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200212 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6670007 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |